Related Experiment Video
Updated: Feb 2, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic Testing and Counseling for Hypertrophic Cardiomyopathy
Allison L Cirino1, Christine E Seidman2, Carolyn Y Ho1
1Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Genetic testing is now more accessible for hypertrophic cardiomyopathy patients. These genetic tests aid in diagnosis and identifying at-risk relatives.
Area of Science:
- Cardiovascular Genetics
- Medical Diagnostics
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant cause of sudden cardiac death.
- Genetic factors play a crucial role in the pathogenesis of HCM.
Purpose of the Study:
- To highlight the increasing role and utility of genetic testing in managing hypertrophic cardiomyopathy.
- To emphasize how genetic testing refines diagnosis and aids in family screening for HCM.
Main Methods:
- Review of current literature on genetic testing in hypertrophic cardiomyopathy.
- Analysis of the diagnostic and prognostic implications of genetic findings in HCM patients.
Main Results:
- Genetic testing is becoming more accessible for patients with hypertrophic cardiomyopathy.
- Test results assist in refining the diagnosis of HCM.
- Genetic information helps differentiate at-risk relatives from unaffected individuals.
Conclusions:
- Genetic testing is an integral part of modern hypertrophic cardiomyopathy care.
- Utilizing genetic testing improves diagnostic accuracy and facilitates targeted screening of at-risk families.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

